JJ
John Josey
Venture Partner at The Column Group
Dallas, Texas
Overview
John Josey is currently a Venture Partner at The Column Group in Dallas, Texas, with a background that includes serving as President and Chief Executive Officer at Peloton Therapeutics, Inc., and Vice President of Discovery Chemistry at Array BioPharma. He has made significant contributions to the biotech and healthcare sectors, investing in companies like Atavistik Bio.
John Josey's career highlights include holding leadership roles at prominent companies in the biotech industry, such as Peloton Therapeutics, Inc., and Array BioPharma, and his current role as a Venture Partner at The Column Group, where he continues to make impactful investments in the healthcare sector.
Work Experience
Venture Partner
2020 - Current
Board Chair
2022
Honored to be working with The Column Group, Lux Capital and Nextech Invest to build a great drug-discovery organization in Cambridge, MA. Particularly delighted that Marion Dorsch, a seasoned drug-hunter, is leading the scientific effort as President & Chief Scientific Officer at Atavistik Bio, Inc.
President and Chief Executive Officer
2013 - 2019
President and Chief Scientific Officer
2011 - 2013
Vice President, Discovery Chemistry
1998 - 2011
Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs.
Raised $412,100,000.00 from Redmile Group.
Scientist
1995 - 1998
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Research Scientist
1991 - 1995